Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 5:53 pm Sale | 13G | JANUX THERAPEUTICS INC JANX | EcoR1 Capital LLC | 0 0% | -3,255,270 (Position Closed) | View |
| 2024-02-14 5:47 pm Sale | 13G | HOOKIPA PHARMA INC HOOK | EcoR1 Capital LLC | 4,595,024 4.8% | -378,465 (-7.61%) | View |
| 2024-02-14 5:41 pm Unchanged | 13G | GALAPAGOS NV SPONSORED ADR GLPG | EcoR1 Capital LLC | 6,505,890 9.9% | 0 (Unchanged) | View |
| 2024-02-14 5:37 pm Purchase | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | EcoR1 Capital LLC | 5,618,779 5.8% | 386,500 (+7.39%) | View |
| 2024-02-14 5:24 pm Purchase | 13G | ARVINAS INC ARVN | EcoR1 Capital LLC | 6,800,493 9.99% | 3,677,193 (+117.73%) | View |
| 2024-02-14 5:18 pm Purchase | 13G | APELLIS PHARMACEUTICALS INC CO APLS | EcoR1 Capital LLC | 11,173,068 9.4% | 4,865,521 (+77.14%) | View |
| 2024-02-14 5:07 pm Purchase | 13G | ALIGOS THERAPEUTICS INC ALGS | EcoR1 Capital LLC | 7,264,147 9.99% | 3,315,787 (+83.98%) | View |
| 2024-02-14 4:37 pm Purchase | 13G | SPYRE THERAPEUTICS, INC SYRE | EcoR1 Capital LLC | 887,076 2.5% | 887,076 (New Position) | View |
| 2024-02-14 4:27 pm Sale | 13G | ADICET BIO INC ACET | EcoR1 Capital LLC | 0 0% | -3,560,700 (Position Closed) | View |
| 2024-02-14 4:15 pm Sale | 13G | ABEONA THERAPEUTICS INC NE ABEO | EcoR1 Capital LLC | 1,086,956 4.2% | -698,707 (-39.13%) | View |
| 2024-02-01 5:11 pm Purchase | 13G | ALLOVIR INC ALVR | EcoR1 Capital LLC | 10,655,366 9.3% | 10,655,366 (New Position) | View |
| 2024-01-30 5:26 pm Purchase | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | EcoR1 Capital LLC | 113,424,420 7.7% | 113,424,420 (New Position) | View |
| 2023-12-27 4:05 pm Purchase | 13G | MIRATI THERAPEUTICS INC MRTX | EcoR1 Capital LLC | 7,396,979 10.5% | 1,648,580 (+28.68%) | View |
| 2023-11-20 7:00 pm Purchase | 13G | ATARA BIOTHERAPEUTICS INC ATRA | EcoR1 Capital LLC | 10,067,043 9.9% | 10,067,043 (New Position) | View |
| 2023-10-16 3:33 pm Purchase | 13G | TANGO THERAPEUTICS INC TNGX | EcoR1 Capital LLC | 13,330,736 13.1% | 5,503,100 (+70.30%) | View |
| 2023-10-12 12:25 pm Purchase | 13G | IMMUNOME INC IMNM | EcoR1 Capital LLC | 3,879,415 9.1% | 3,879,415 (New Position) | View |
| 2023-10-02 4:08 pm Purchase | 13G | MIRATI THERAPEUTICS INC MRTX | EcoR1 Capital LLC | 5,748,399 8.5% | 5,748,399 (New Position) | View |
| 2023-09-21 5:16 pm Purchase | 13G | TANGO THERAPEUTICS INC TNGX | EcoR1 Capital LLC | 7,827,636 7.7% | 7,827,636 (New Position) | View |
| 2023-09-13 5:02 pm Purchase | 13G | THIRD HARMONIC BIO INC THRD | EcoR1 Capital LLC | 2,982,444 7.4% | 2,982,444 (New Position) | View |
| 2023-07-27 5:11 pm Purchase | 13G | MERSANA THERAPEUTICS INC MRSN | EcoR1 Capital LLC | 19,364,688 16.9% | 19,364,688 (New Position) | View |